Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse - PubMed (original) (raw)
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse
R A Greenberg et al. Cell. 1999.
Free article
Abstract
Maintenance of telomere length is predicted to be essential for bypass of senescence and crisis checkpoints in cancer cells. The impact of telomere dysfunction on tumorigenesis was assessed in successive generations of mice doubly null for the telomerase RNA (mTR) and the INK4a tumor suppressor genes. Significant reductions in tumor formation in vivo and oncogenic potential in vitro were observed in late generations of telomerase deficiency, coincident with severe telomere shortening and associated dysfunction. Reintroduction of mTR into cells significantly restored the oncogenic potential, indicating telomerase activation is a cooperating event in the malignant transformation of cells containing critically short telomeres. The results described here demonstrate that loss of telomere function in a cancer-prone mouse model possessing intact DNA damage responses impairs, but does not prevent, tumor formation.
Similar articles
- Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Khoo CM, Carrasco DR, Bosenberg MW, Paik JH, Depinho RA. Khoo CM, et al. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3931-6. doi: 10.1073/pnas.0700093104. Epub 2007 Feb 27. Proc Natl Acad Sci U S A. 2007. PMID: 17360455 Free PMC article. - p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
Wang Y, Sharpless N, Chang S. Wang Y, et al. J Clin Invest. 2013 Oct;123(10):4489-501. doi: 10.1172/JCI69574. Epub 2013 Sep 16. J Clin Invest. 2013. PMID: 24091330 Free PMC article. - Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression.
Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Chang S, et al. Genes Dev. 2003 Jan 1;17(1):88-100. doi: 10.1101/gad.1029903. Genes Dev. 2003. PMID: 12514102 Free PMC article. - Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence.
Yang DG, Liu L, Zheng XY. Yang DG, et al. Ageing Res Rev. 2008 Apr;7(2):137-46. doi: 10.1016/j.arr.2008.02.001. Epub 2008 Feb 12. Ageing Res Rev. 2008. PMID: 18343732 Review. - Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Roake CM, Artandi SE. Roake CM, et al. Cold Spring Harb Perspect Med. 2017 May 1;7(5):a026088. doi: 10.1101/cshperspect.a026088. Cold Spring Harb Perspect Med. 2017. PMID: 28289249 Free PMC article. Review.
Cited by
- Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes.
Bisht S, Mao Y, Easwaran H. Bisht S, et al. Curr Opin Oncol. 2024 Mar 1;36(2):82-92. doi: 10.1097/CCO.0000000000001020. Epub 2024 Jan 17. Curr Opin Oncol. 2024. PMID: 38441107 Review. - Humanization of the mouse Tert gene reset telomeres to human length.
Cheng D, Zhang F, Porter KI, Wang S, Zhang H, Davis CJ, Robertson GP, Zhu J. Cheng D, et al. Res Sq [Preprint]. 2024 Jan 5:rs.3.rs-3617723. doi: 10.21203/rs.3.rs-3617723/v1. Res Sq. 2024. PMID: 38260456 Free PMC article. Preprint. - Regulation of telomerase towards tumor therapy.
Yan S, Lin S, Qiu H, Wang X, He Y, Wang C, Huang Y. Yan S, et al. Cell Biosci. 2023 Dec 18;13(1):228. doi: 10.1186/s13578-023-01181-6. Cell Biosci. 2023. PMID: 38111043 Free PMC article. Review. - Telomere dysfunction in Tert knockout mice delays BrafV600E -induced melanoma development.
Zhang J, Zhang F, Porter KI, Dakup PP, Wang S, Robertson GP, Gaddameedhi S, Zhu J. Zhang J, et al. Int J Cancer. 2024 Feb 1;154(3):548-560. doi: 10.1002/ijc.34713. Epub 2023 Sep 20. Int J Cancer. 2024. PMID: 37727982 - T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers.
Schratz KE, Flasch DA, Atik CC, Cosner ZL, Blackford AL, Yang W, Gable DL, Vellanki PJ, Xiang Z, Gaysinskaya V, Vonderheide RH, Rooper LM, Zhang J, Armanios M. Schratz KE, et al. Cancer Cell. 2023 Apr 10;41(4):807-817.e6. doi: 10.1016/j.ccell.2023.03.005. Epub 2023 Apr 2. Cancer Cell. 2023. PMID: 37037617 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases